The Latest Breaking News from HUM

As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. (NYSE:HUM) is adapting to these changes through strategic adjustments. This adaptability is reflected in their second-quarter earnings report, which exceeded analysts’ expectations despite a decline in adjusted EPS compared to last year.

Humana Inc. NYSE: HUM) on Tuesday announced accelerated efforts to approve care requests as quickly as possible and reduce the administrative burden for physicians associated with prior authorization.

Humana is expected to release its fiscal first-quarter earnings later this month, and analysts project a double-digit profit rise.

Although Humana has underperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%

Humana has underperformed the broader market by a large margin over the past year and analysts remain cautiously bullish on the stock’s prospects.

Humana is set to release its fourth-quarter results later this month, with analysts anticipating a significant drop in earnings.

Humana has substantially underperformed the S&P 500 over the past year and analysts remain cautiously bullish on the stock’s prospects.

UnitedHealth rose after a federal judge ordered a rerating of the Dow Jones giant's Medicare Star Ratings.